We need you! See something you could improve? Make an edit and help make WikEM better for everyone.

Tirzepatide

Revision as of 17:43, 18 August 2022 by Kfarzam (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment

Retrieved from "https://www.wikem.org/w/index.php?title=Tirzepatide&oldid=365743"

Pharmacology

Authors:

Khashayar Farzam